Myung In Pharmaceutical LTD. (KRX:317450)
56,900
+600 (1.07%)
At close: Apr 8, 2026
KRX:317450 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 31,792 | 32,897 | 34,449 | 18,251 | 52,967 |
Short-Term Investments | 477,901 | 227,399 | 153,080 | 124,434 | 67,786 |
Cash & Short-Term Investments | 509,692 | 260,296 | 187,529 | 142,686 | 120,753 |
Cash Growth | 95.81% | 38.80% | 31.43% | 18.16% | 70.83% |
Accounts Receivable | 63,651 | 60,771 | 58,147 | 56,783 | 56,688 |
Other Receivables | 5,055 | 3,492 | 3,711 | 2,710 | 2,138 |
Receivables | 68,870 | 64,433 | 62,020 | 59,646 | 59,033 |
Inventory | 64,108 | 60,343 | 56,277 | 47,880 | 46,732 |
Prepaid Expenses | 538.02 | 510.71 | 434.13 | 533.52 | 243.22 |
Other Current Assets | 100.97 | 225.49 | 1,329 | 72.68 | 176.49 |
Total Current Assets | 643,309 | 385,809 | 307,589 | 250,818 | 226,938 |
Property, Plant & Equipment | 118,513 | 99,259 | 99,309 | 103,706 | 110,187 |
Long-Term Investments | 10,219 | 10,783 | 28,608 | 24,242 | 6,804 |
Other Intangible Assets | 5,520 | 713.02 | 710.9 | 711.01 | 711.69 |
Long-Term Accounts Receivable | 1,924 | 2,231 | 2,039 | 2,300 | 2,545 |
Long-Term Deferred Tax Assets | - | - | - | - | 4.51 |
Other Long-Term Assets | 61,943 | 82,717 | 83,119 | 89,528 | 82,344 |
Total Assets | 841,675 | 581,692 | 521,590 | 471,556 | 429,760 |
Accounts Payable | 6,301 | 8,298 | 2,397 | 2,129 | 2,245 |
Accrued Expenses | 1,207 | 1,327 | 1,425 | 1,296 | 2,290 |
Current Portion of Leases | 1,175 | 1,528 | 1,727 | 1,739 | 1,329 |
Current Income Taxes Payable | 11,458 | 12,389 | 12,949 | 11,472 | 13,494 |
Current Unearned Revenue | 17.32 | - | - | - | - |
Other Current Liabilities | 26,026 | 21,059 | 20,686 | 18,458 | 20,374 |
Total Current Liabilities | 46,184 | 44,602 | 39,184 | 35,093 | 39,732 |
Long-Term Leases | 211.16 | 1,172 | 2,160 | 3,206 | 4,281 |
Long-Term Unearned Revenue | 7.29 | 70.23 | 115.85 | 161.47 | - |
Pension & Post-Retirement Benefits | - | - | - | - | 668.61 |
Long-Term Deferred Tax Liabilities | 1.66 | 1,439 | 5,327 | 6,684 | 6,605 |
Other Long-Term Liabilities | 892.39 | 2,589 | 2,489 | 2,432 | 2,382 |
Total Liabilities | 47,297 | 49,871 | 49,276 | 47,577 | 53,668 |
Common Stock | 7,300 | 5,600 | 5,600 | 5,600 | 5,600 |
Additional Paid-In Capital | 192,082 | - | - | - | - |
Retained Earnings | 602,371 | 533,269 | 471,701 | 421,245 | 373,297 |
Comprehensive Income & Other | -7,375 | -7,049 | -4,988 | -2,866 | -2,805 |
Shareholders' Equity | 794,378 | 531,821 | 472,314 | 423,979 | 376,092 |
Total Liabilities & Equity | 841,675 | 581,692 | 521,590 | 471,556 | 429,760 |
Total Debt | 1,386 | 2,700 | 3,887 | 4,945 | 5,609 |
Net Cash (Debt) | 508,306 | 257,596 | 183,642 | 137,740 | 115,143 |
Net Cash Growth | 97.33% | 40.27% | 33.32% | 19.63% | 80.64% |
Net Cash Per Share | 41932.70 | 22998.48 | 16396.62 | 12298.25 | 10280.65 |
Filing Date Shares Outstanding | 14.63 | 11.2 | 11.2 | 11.2 | 11.2 |
Total Common Shares Outstanding | 14.63 | 11.2 | 11.2 | 11.2 | 11.2 |
Working Capital | 597,125 | 341,207 | 268,406 | 215,724 | 187,206 |
Book Value Per Share | 54305.30 | 47483.98 | 42170.89 | 37855.28 | 33579.64 |
Tangible Book Value | 788,858 | 531,108 | 471,603 | 423,268 | 375,380 |
Tangible Book Value Per Share | 53927.95 | 47420.31 | 42107.41 | 37791.80 | 33516.10 |
Land | 39,466 | 39,467 | 39,089 | 37,098 | 36,955 |
Buildings | 59,273 | 59,179 | 59,291 | 59,020 | 58,923 |
Machinery | 98,430 | 95,865 | 90,304 | 87,403 | 85,970 |
Construction In Progress | 30,916 | 5,236 | 1,374 | 258.5 | 286.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.